dc.creatorAlmeida, Liz María de
dc.creatorCortés, Sandra
dc.creatorVilensky, Marta
dc.creatorValenzuela, Olivia
dc.creatorCortés Sanabria, Laura
dc.creatorSouza, Mirian de
dc.creatorBarbeito, Rafael Alonso
dc.creatorAbdelhay, Eliana
dc.creatorArtagaveytia, Nora
dc.creatorDaneri Navarro, Adrian
dc.creatorLlera, Andrea S.
dc.creatorMüller, Bettina
dc.creatorPodhajcer, Osvaldo L.
dc.creatorVelázquez, Carlos
dc.creatorAlcoba, Elsa
dc.creatorAlonso, Isabel
dc.creatorBravo, Alicia I.
dc.creatorCamejo, Natalia
dc.creatorCarraro, Dirce Maria
dc.creatorCastro, Mónica
dc.creatorCataldi, Sandra
dc.creatorCayota, Alfonso
dc.creatorCerda Villablanca, Mauricio David
dc.creatorColombo Flores, Alicia Angelina
dc.creatorCrocamo, Susanne
dc.creatorToro Arreola, Alicia del
dc.creatorDelgadillo Cristerna, Raúl
dc.creatorDelgado, Lucia
dc.creatorBreitenbach, Marisa Dreyer
dc.creatorFernández, Elmer
dc.creatorFernández, Jorge
dc.creatorFernández, Wanda
dc.creatorFranco Topete, Ramón A
dc.creatorGaete, Fancy
dc.creatorGómez, Jorge
dc.creatorGonzález Ramírez, Leivy P.
dc.creatorGuerrero, Marisol
dc.creatorGutiérrez Rubio, Susan A.
dc.creatorJalfin, Beatriz
dc.creatorLópez Vázquez, Alejandra
dc.creatorLoria, Dora
dc.creatorMíguez, Silvia
dc.creatorMorán Mendoza, Andres de J.
dc.creatorMorgan Villela, Gilberto
dc.creatorMussetti, Carina
dc.creatorNagai, Maria Aparecida
dc.creatorOceguera Villanueva, Antonio
dc.creatorReis, Rui M.
dc.creatorRetamales, Javier
dc.creatorRodríguez, Robinson
dc.creatorRosales, Cristina
dc.creatorSalas González, Efraín
dc.creatorSegovia, Laura
dc.creatorSendoya, Juan M.
dc.creatorSilva García, Aída A.
dc.creatorViña, Stella
dc.creatorZagame, Livia
dc.creatorJones, Beth
dc.creatorSzklo, Moysés
dc.date.accessioned2022-11-24T20:40:14Z
dc.date.accessioned2023-05-19T00:55:55Z
dc.date.available2022-11-24T20:40:14Z
dc.date.available2023-05-19T00:55:55Z
dc.date.created2022-11-24T20:40:14Z
dc.date.issued2022
dc.identifierFrontiers in Oncology March 2022 Volume 12 Article 845527
dc.identifier10.3389/fonc.2022.845527
dc.identifierhttps://repositorio.uchile.cl/handle/2250/189371
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/6297524
dc.description.abstractMolecular profile of breast cancer in Latin-American women was studied in five countries: Argentina, Brazil, Chile, Mexico, and Uruguay. Data about socioeconomic characteristics, risk factors, prognostic factors, and molecular subtypes were described, and the 60-month overall cumulative survival probabilities (OS) were estimated. From 2011 to 2013, 1,300 eligible Latin-American women 18 years or older, with a diagnosis of breast cancer in clinical stage II or III, and performance status not less than or equal to 1 were invited to participate in a prospective cohort study. Face-to-face interviews were conducted, and clinical and outcome data, including death, were extracted from medical records. Unadjusted associations were evaluated by Chi-squared and Fisher's exact tests and the OS by Kaplan-Meier method. Log-rank test was used to determine differences between cumulative probability curves. Multivariable adjustment was carried out by entering potential confounders in the Cox regression model. The OS at 60 months was 83.9%. Multivariable-adjusted death hazard differences were found for women living in Argentina (2.27), Chile (1.95), and Uruguay (2.42) compared with Mexican women, for older (>= 60 years) (1.84) compared with younger (<= 40 years) women, for basal-like subtype (5.8), luminal B (2.43), and HER2-enriched (2.52) compared with luminal A subtype, and for tumor clinical stages IIB (1.91), IIIA (3.54), and IIIB (3.94) compared with stage IIA women. OS was associated with country of residence, PAM50 intrinsic subtype, age, and tumor stage at diagnosis. While the latter is known to be influenced by access to care, including cancer screening, timely diagnosis and treatment, including access to more effective treatment protocols, it may also influence epigenetic changes that, potentially, impact molecular subtypes. Data derived from heretofore understudied populations with unique geographic ancestry and sociocultural experiences are critical to furthering our understanding of this complexity.
dc.languageen
dc.publisherFrontiers Media
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/3.0/us/
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 United States
dc.sourceFrontiers in Oncology
dc.subjectGlobal excellence
dc.subjectOncology
dc.subjectLatin America
dc.subjectBreast cancer
dc.subjectMolecular subtypes
dc.subjectRisk factors
dc.subjectPrognosis
dc.titleSocioeconomic, clinical, and molecular features of breast cancer influence overall survival of Latin American women
dc.typeArtículo de revista


Este ítem pertenece a la siguiente institución